Baxter International (BAX) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0718131099

Baxter International Inc. is a global company that develops and supplies a wide range of healthcare products across the world. The company operates through four key segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care.

Some of the products offered by Baxter include sterile intravenous solutions, infusion systems, parenteral nutrition therapies, generic injectable pharmaceuticals, surgical hemostat products, advanced surgical equipment, patient monitoring technologies, respiratory health devices, and more. The company also provides various services like administrative sets, drug compounding, chronic and acute dialysis therapies, including peritoneal and hemodialysis, and other organ support therapies.

Baxter's products are used in a variety of healthcare settings such as hospitals, dialysis centers, nursing homes, rehabilitation centers, and doctors' offices. Additionally, patients can use Baxter's products at home under physician supervision. The company operates in approximately 100 countries and distributes its products through direct sales, independent distributors, drug wholesalers, and specialty pharmacies.

Established in 1931 and headquartered in Deerfield, Illinois, Baxter International Inc. collaborates with various partners to develop innovative healthcare solutions. It has agreements with companies like Celerity Pharmaceutical, LLC and Miromatrix Medical Inc., aiming to enhance patient care in acute care settings.

For more information about Baxter International Inc., visit their website at https://www.baxter.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Baxter International (BAX) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Baxter International (BAX) - Stock & Dividends

BAX Stock Overview

Market Cap in USD 21,713m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1981-10-27

BAX Stock Ratings

Growth 5y -3.84
Fundamental -8.60
Dividend 7.11
Rel. Performance vs Sector -1.28
Analysts 3.59/5
Fair Price Momentum 43.38 USD
Fair Price DCF 56.77 USD

BAX Dividends

Yield 12m 2.83%
Yield on Cost 5y 1.66%
Dividends CAGR 5y 6.42%
Payout Consistency 94.3%

BAX Growth Ratios

Growth 12m -7.06%
Growth Correlation 12m -14%
Growth Correlation 3m 36%
CAGR 5y -10.08%
Sharpe Ratio 12m -0.45
Alpha vs SP500 12m -22.87
Beta vs SP500 5y weekly 0.50
ValueRay RSI 42.85
Volatility GJR Garch 1y 23.35%
Price / SMA 50 -1.58%
Price / SMA 200 4.78%
Current Volume 2646.3k
Average Volume 20d 3217.3k

External Links for BAX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BAX stocks?
As of April 24, 2024, the stock is trading at USD 41.02 with a total of 2,646,343 shares traded.
Over the past week, the price has changed by +3.66%, over one month by -2.19%, over three months by +7.52% and over the past year by -6.98%.
What is the forecast for BAX stock price target?
According to ValueRays Forecast Model, BAX Baxter International will be worth about 46.9 in April 2025. The stock is currently trading at 41.02. This means that the stock has a potential upside of +14.21%.
Issuer Forecast Upside
Wallstreet Target Price 45 9.70
Analysts Target Price 47.1 14.8
ValueRay Target Price 46.9 14.2